Search results for "PAM"

showing 10 items of 1768 documents

Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with age

2007

Molecular and functional imaging techniques reveal evidence for lateralization of human cerebral function. Based on animal data, we hypothesized that asymmetry in dopamine neurotransmission declines during normal aging. In order to test this hypothesis, we measured dopamine D2/3 receptor availability with [18F]desmethoxyfallypride-PET (DMFP) in putamen and caudate nucleus (NC) of 21 healthy, right-handed males (24-60 years; 35+/-10). For volumetric analysis, high-resolution T1-weighted MR-images were obtained in 18 of the PET-subjects in order to assess possible age-related decreases in NC and putamen volume. The calculated DMFP binding potentials (BP) showed a right-ward asymmetry in NC of…

AdultMaleAgingmedicine.medical_specialtyCognitive NeuroscienceCaudate nucleusNeurotransmissionFunctional LateralityLateralization of brain functionAnimal dataDopamineDopamine receptor D2Internal medicineSalicylamidesmedicineHumansTissue DistributionReceptors Dopamine D2PutamenReceptors Dopamine D3Middle AgedEndocrinologyNeurologyDopamine receptorPositron-Emission TomographyCaudate NucleusRadiopharmaceuticalsPsychologyNeurosciencemedicine.drugNeuroImage
researchProduct

Roxindole, a dopamine autoreceptor agonist, in the treatment of major depression

1993

Roxindole is a potent autoreceptor-“selective” dopamine agonist originally developed for the treatment of schizophrenic syndromes. The drug also inhibits 5-HT uptake and has 5-HT1A agonistic actions. In this open clinical trial 12 in-patients suffering from a major depressive episode (DSM-III-R) were treated with roxindole for 28 days in a fixed dosage of 15 mg per day. A reduction of at least 50% in HAMD-17 total scores was observed in 8 out of 12 patients after 4 weeks (mean HAMD-17 reduction of 56% in all patients), while 4 patients did not respond to roxindole treatment. Half of the patients showed a complete psychopathological remission (HAMD-17 <8). Roxindole's onset of antidepressant…

AdultMaleAgonistIndolesPyridinesmedicine.drug_classPharmacologyDopamine agonistAsymptomaticchemistry.chemical_compoundRoxindoleDopaminemedicineHumansPharmacology (medical)Major depressive episodePsychiatric Status Rating ScalesPharmacologyDepressive Disorderbusiness.industryMiddle AgedOxindolesProlactinchemistryDopamine receptorAnesthesiaDopamine AgonistsAutoreceptorAntidepressantFemaleNeurology (clinical)medicine.symptombusinessPsychologymedicine.drugPsychopharmacology
researchProduct

Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence

2002

Due to a central role of dopamine in mediating ethanol intake and dependence, the authors tested lisuride, a dopamine D2 receptor agonist, for relapse prevention in alcoholics. Psychological and neuroendocrine determinants of outcome were also assessed within the study. This double-blind, placebo-controlled randomized study comprised 120 alcoholics who were subjected to an intend-to-treat analysis (ITT). After hospital detoxification, patients received an outpatient rehabilitation program and either the study medication or placebo for 6 months and follow-up for another 6 months without medication. Pharmacological and psychological effects on relapse and times to first drink were assessed us…

AdultMaleAgonistmedicine.medical_specialtymedicine.drug_classPharmacologyRelapse preventionDopamine agonistDouble-Blind MethodDopamineInternal medicineDopamine receptor D2Secondary PreventionmedicineHumansProspective StudiesLisurideBiological PsychiatryPharmacologyChi-Square DistributionReceptors Dopamine D2DopaminergicMiddle AgedSurvival AnalysisBehavior AddictiveApomorphineAlcoholismEndocrinologyFemalePsychologyFollow-Up Studiesmedicine.drugLisurideProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Altered benzodiazepine receptor sensitivity in alcoholism: a study with fMRI and acute lorazepam challenge.

2007

Previous studies suggested altered sensitivity of the GABA/benzodiazepine receptor system in alcoholic patients. Expanding on these findings, the present functional magnetic resonance imaging (fMRI) study aimed to assess whether a differential modulation of cognitive brain activation by an acute GABAergic drug challenge could be detected in patients with alcoholism. Eight detoxified male patients meeting DSM-IV criteria for alcohol dependence and nine healthy male control subjects were studied with fMRI while performing a 2-back working memory task. The fMRI scans were performed 1 h after intravenous administration of saline and again 1 h after 0.03 mg/kg lorazepam I.V. After saline, a task…

AdultMaleCerebellummedicine.medical_specialtyPsychometricsmedicine.drug_classNeuroscience (miscellaneous)Prefrontal CortexLorazepamDrug Administration ScheduleInternal medicineCerebellummedicineHumansRadiology Nuclear Medicine and imagingGABA ModulatorsBenzodiazepineMemory Disordersmedicine.diagnostic_testWorking memoryAlcohol dependenceLorazepamReceptors GABA-AMagnetic Resonance ImagingFunctional imagingPsychiatry and Mental healthAlcoholismmedicine.anatomical_structureEndocrinologySedativePsychologyFunctional magnetic resonance imagingCognition DisordersNeuroscienceChlormethiazolemedicine.drugPsychiatry research
researchProduct

Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge

2005

Summary Objective To verify findings of an independently regulated anterior limbic alpha band source. Methods In a randomised cross-over study, the spontaneous EEG was recorded in nine healthy subjects after i.v. lorazepam or placebo. Intracerebral current densities within classical frequency bands were estimated with low resolution electromagnetic tomography [LORETA] and compared between groups with t -statistical parametric mapping [SPM{ t }]. A region-of-interest [ROI] based method was used to compare frontal and occipital alpha band activity changes. Results Irrespective of treatment group, local maxima of alpha band power were localised both in the occipital lobe, Brodman area [BA] 18,…

AdultMaleCingulate cortexFrequency bandAlpha (ethology)ElectroencephalographyLorazepamStatistical parametric mappingStatistics NonparametricElectromagnetic FieldsNuclear magnetic resonanceLimbic systemPhysiology (medical)mental disordersLimbic SystemmedicineHumansSingle-Blind MethodAnterior cingulate cortexPhysicsCross-Over Studiesmedicine.diagnostic_testSensory SystemsAlpha Rhythmmedicine.anatomical_structureNeurologyInjections IntravenousNeurology (clinical)Occipital lobeNeuroscienceClinical Neurophysiology
researchProduct

A ventral striatal prediction error signal in human fear extinction learning.

2021

Animal studies have shown that the prediction error (PE) signal that drives fear extinction learning is encoded by phasic activity of midbrain dopamine (DA) neurons. Thus, the extinction PE resembles the appetitive PE that drives reward learning. In humans, fear extinction learning is less well understood. Using computational neuroimaging, a previous study from our group reported hemodynamic activity in the left ventral putamen, a subregion of the ventral striatum (VS), to correlate with a PE function derived from a formal associative learning model. The activity was modulated by genetic variation in a DA-related gene. To conceptually replicate and extend this finding, we here asked whether…

AdultMaleCognitive NeuroscienceBiology050105 experimental psychologylcsh:RC321-571Extinction PsychologicalMidbrain03 medical and health sciencesYoung Adult0302 clinical medicineNeuroimagingDopaminemedicineHumansLearning0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryPutamen05 social sciencesVentral striatumExtinction (psychology)FearGalvanic Skin ResponseMagnetic Resonance ImagingElectric StimulationAssociative learningmedicine.anatomical_structureNeurologyVentral StriatumFemaleAnimal studiesNeuroscience030217 neurology & neurosurgeryPhotic Stimulationmedicine.drugForecastingNeuroImage
researchProduct

Amelanotic conjunctival melanoma

2006

Conjunctival melanoma is a rare condition of the eye pigment predominantly affecting white adults. We describe a 32-year-old white man with an amelanotic malignant melanoma of the conjunctiva that is not associated with primary acquired melanosis (PAM) or melanocytic nevus. The patient presented with a 2-year history of nonpigmented vascularized nodules of the right eye. Results of hematoxylin and eosin (H and E) staining of the lesion showed an invasive nodule with vertical spreading, invasion of the substantia propria corneae, and ulceration. S100 protein was expressed in the cells of the invasive nodule. HMB45 protein was highly positive in the melanoma cells. The de novo amelanotic mali…

AdultMaleConjunctival melanomaprimary acquired melanosis (PAM).HumansConjunctival NeoplasmsMelanoma AmelanoticConjunctivaImmunohistochemistryamelanotic malignant melanoma
researchProduct

High Iodine Concentration Contrast Material for Noninvasive Multislice Computed Tomography Coronary Angiography

2006

OBJECTIVE: The objective of this study was to compare intracoronary attenuation on 16-row multislice computed tomography (16-MSCT) coronary angiography using 2 contrast materials (CM) with high iodine concentration. MATERIAL AND METHODS: Forty consecutive patients (29 male, 11 female; mean age, 61 ± 11 years) with suspected coronary artery disease were randomized to 2 groups to receive 100 mL of either iopromide 370 (group 1: Ultravist 370, 370 mg iodine/mL; Schering AG, Berlin, Germany) or iomeprol 400 (group 2: Iomeron 400, 400 mg iodine/mL; Bracco Imaging SpA, Milan, Italy). Both CM were administered at a rate of 4 mL/s. All patients underwent 16-MSCT coronary angiography (Sensation 16; …

AdultMaleCoronary angiographymedicine.medical_specialtyIohexolmedia_common.quotation_subjectContrast MediaCoronary Artery DiseasemedicineHumansContrast (vision)Radiology Nuclear Medicine and imagingHigh iodineAgedmedia_commonbusiness.industryIopromideMean ageGeneral MedicineMultislice computed tomographyMiddle AgedIopamidolcontrast materialIomeprol 400Injections IntravenousFemaleRadiologyTomographycoronary angiographyTomography X-Ray Computediodine concentrationbusiness16-row multislice CTmedicine.drugInvestigative Radiology
researchProduct

A Nonlinear Approach to Brain Function: Deterministic Chaos and Sleep EEG

1992

In order to perform a nonlinear dimensional analysis of the sleep electroencephalogram (EEG), we applied an algorithm proposed by Grassberger and Procaccia to calculate the correlation dimension D2 of different sleep stages under Lorazepam medication versus placebo. This correlation dimension characterizes the dynamics of the sleep EEG and it estimates the degrees of freedom of the signal under study. We demonstrate that slow-wave sleep depicts a much smaller dimensionality than light or rapid eye movement (REM) sleep, and that Lorazepam does not alter the EEG's dimensionality except in stage II and REM.

AdultMaleCorrelation dimensionRapid eye movement sleepSleep REMElectroencephalographyLorazepamHippocampusModels BiologicalPhysiology (medical)mental disordersmedicineAnimalsHumansSlow-wave sleepAuditory CortexSleep Stagesmedicine.diagnostic_testbusiness.industryBrainEye movementElectroencephalographyPattern recognitionPlacebo EffectSleep in non-human animalsElectrodes ImplantedCatsSleep StagesNeurology (clinical)Artificial intelligenceSleepbusinessPsychologyNeuroscienceCurse of dimensionalitySleep
researchProduct

Strange Attractors, Chaotic Behavior and Informational Aspects of Sleep EEG Data

1992

In order to perform a nonlinear dimensional analysis of the sleep EEG, we applied an algorithm proposed to calculate the correlation dimension D2 of different sleep stages. D2 characterizes the dynamics of the sleep EEG, estimates the degrees of freedom, and describes the complexity of the signal under study. An attempt is made to correlate dimensionality analysis and informational aspects of the sleep EEG. Information processing by the brain during different sleep stages of healthy subjects under the influence of lorazepam and in unmedicated acute schizophrenics is estimated.

AdultMaleCorrelation dimensionmedia_common.quotation_subjectChaoticElectroencephalographyLorazepamInformation theoryAttractormedicineHumansElectrodesBiological Psychiatrymedia_commonSleep Stagesmedicine.diagnostic_testInformation processingElectroencephalographyPsychiatry and Mental healthNeuropsychology and Physiological PsychologyAcute DiseaseFemaleSchizophrenic PsychologySleep StagesSleepPsychologyNeuroscienceAlgorithmsCognitive psychologyVigilance (psychology)Neuropsychobiology
researchProduct